TABLE 1.

Patient demographics and clinical risk factors among the subset of patients without ovarian cancer (n = 87)

	N = 87 patients
	Patients with breast cancer (N = 67)	Patients without breast cancer (N = 20)
Age at VUS diagnosis, median (range)	49 (27–83)	45 (30–74)
Menopausal status, n (%)
Premenopausal	36 (54%)	8 (40%)
Perimenopausal	3 (4%)	1 (5%)
Postmenopausal	24 (36%)	8 (40%)
Unknown	4 (6%)	3 (15%)
Year of VUS diagnosis, n (%)
2000–2005	7 (10%)	2 (10%)
2006–2011	26 (39%)	9 (45%)
2012–2016	28 (42%)	9 (45%)
Unknown	6 (9%)	-
Gene with VUS, n (%)
BRCA1	21 (31%)	4 (20%)
BRCA2	46 (69%)	16 (80%)
Gender, n (%)
Female	67 (100%)	18 (90%)
Male	0	2 (10%)
Ethnicity, n (%)
Caucasian	59 (88%)	18 (90%)
African American	0	0
Hispanic	2 (3%)	0
Asian	2 (3%)	0
Other/unknown	3 (4%)	2 (10%)
Marital status, n (%)
Single	7 (10%)	0
Married	47 (70%)	18 (90%)
Widowed	6 (9%)	0
Divorced	7 (10%)	2 (10%)
Education, n (%)
High school	8 (12%)	4 (20%)
College	34 (51%)	10 (50%)
Graduate	16 (24%)	3 (15%)
Unknown	9 (13%)	3 (15%)
Tyrer-Cuzick (IBIS), median (range)	-	27% (16–62%)
Gail (lifetime), median (range)	-	20% (7–43%)
# Relatives with breast cancer, median (range)	2(0–9)	3 (1–6)
First-degree family history, n (%) (unknown n = 2)	29/65 (45%)	16/20 (80%)